ChemMedChem

期刊简介：Quality research. Outstanding publications. With an impact factor of 3.124 (2019), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. It is published on behalf of Chemistry Europe, an association of 16 European chemical societies.ChemMedChem publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.ContentsChemMedChem publishes an attractive mixture of:Full Papers and CommunicationsReviews and MinireviewsPatent ReviewsHighlights and ConceptsBook and Multimedia Reviews.

【译文】高质量研究。杰出出版物。凭借2019年的影响因子3.124，ChemMedChem是化学、生物学和医学交叉研究领域的顶级期刊。它由Chemistry Europe代表16个欧洲化学学会出版。ChemMedChem发表来自世界各地的作者的原创新信息以及批判性的次级和三级信息。其使命是整合广泛的药物和制药科学领域，从药物设计和发现到药物开发和递送，从分子建模到组合化学，从靶点验证到先导化合物生成和ADMET研究。ChemMedChem通常涵盖小分子、治疗性大分子、肽、肽类似物和aptamer、蛋白-药物偶联物、核酸疗法等内容，以及从2017年开始的纳米医学，特别是1）靶向纳米递送，2）诊断治疗纳米颗粒和3）纳米药物。内容ChemMedChem发表了一系列吸引人的内容：全文和通讯、综述和迷你综述、专利综述、亮点和概念、书籍和多媒体评论。